Cellectis SA (CLLS)
2.52
-0.10
(-3.81%)
USD |
NASDAQ |
Apr 24, 16:00
2.52
0.00 (0.00%)
After-Hours: 20:00
Cellectis Cash from Financing (TTM): 36.24M for Sept. 30, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | 36.24M |
June 30, 2023 | 30.44M |
March 31, 2023 | 13.25M |
December 31, 2022 | 1.145M |
September 30, 2022 | 4.764M |
June 30, 2022 | 5.202M |
March 31, 2022 | 45.41M |
December 31, 2021 | 47.52M |
September 30, 2021 | 61.62M |
June 30, 2021 | 81.85M |
March 31, 2021 | 39.01M |
December 31, 2020 | 27.32M |
September 30, 2020 | 13.62M |
June 30, 2020 | -3.761M |
March 31, 2020 | -4.483M |
December 31, 2019 | -3.862M |
Date | Value |
---|---|
September 30, 2019 | -2.673M |
June 30, 2019 | 0.078M |
March 31, 2019 | 231.73M |
December 31, 2018 | 236.49M |
September 30, 2018 | 237.28M |
June 30, 2018 | 274.55M |
March 31, 2018 | 44.47M |
December 31, 2017 | 41.27M |
September 30, 2017 | 40.37M |
June 30, 2017 | 1.336M |
March 31, 2017 | 0.4757M |
December 31, 2016 | 0.485M |
September 30, 2016 | 0.863M |
June 30, 2016 | 1.770M |
March 31, 2016 | 220.56M |
December 31, 2015 | 220.59M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-4.483M
Minimum
Mar 2020
81.85M
Maximum
Jun 2021
21.82M
Average
13.43M
Median
Cash from Financing (TTM) Benchmarks
DBV Technologies SA | 6.767M |
Biophytis SA | 7.617M |
Genfit SA | -- |
Edap TMS SA | -0.9863M |
Biodexa Pharmaceuticals Plc | 12.76M |